Orbus Therapeutics Enters Exclusive License Agreement for Intellectual Property Related to …
By
Jan 11, 2023
PALO ALTO, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) — Orbus Therapeutics Inc., a private, late-stage biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases, announced
